Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation, a provider of life-science research tools and services, have announced a strategic partnership around the automation of the cell isolation phase of cell therapy manufacturing, reducing the complexity of this laborious process.   The current method of performing cell isolation using immunomagnetic beads manually is complex and time-consuming. By utiliz...